Bharat Parenterals Complete Financial Statements
BPLPHARMA • Review detailed financials to uncover trends, confirm thesis & journal trades
10 Years of Data
2025 - 2016
Complete Financial Data Export
Export complete financial statements for Bharat Parenterals (BPLPHARMA).
Downloads include all available records across all periods.
For market performance, see the
BPLPHARMA stock price today
.
Profitability Ratios
Net Profit Margin
-13.24%
2025 data
EBITDA Margin
5.88%
2025 data
Operating Margin
1.00%
2025 data
Return on Assets
-1.39%
2025 data
Return on Equity
-2.65%
2025 data
Balance Sheet Ratios
Current Ratio
3.96
2025 data
Debt to Equity
1.91
2025 data
Equity Ratio
52.23%
2025 data
Asset Turnover
0.10
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
-10.5%
Year-over-Year
Net Profit Growth
+50.0%
Year-over-Year
EBITDA Growth
+200.0%
Year-over-Year
Expense Growth
-19.0%
Year-over-Year
Assets Growth
+28.8%
Year-over-Year
Equity Growth
+42.4%
Year-over-Year
Liabilities Growth
+28.8%
Year-over-Year
Operating Cash Flow Growth
-440.0%
Year-over-Year
Investing Cash Flow Growth
-30.5%
Year-over-Year
Financing Cash Flow Growth
+41.8%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Jun 2018 | Dec 2018 | Sept 2017 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 68 | 106 | 117 | 76 | 71 | 95 | 75 | 62 | 51 | 72 | 61 | 88 | 55 | 28 | 63 | 63 | 42 | 63 | 40 | 62 | 57 | 57 | 52 | 53 | 46 | 53 | 77 | 52 | 40 | 94 | 37 | 32 | 27 |
| Expenses | 64 | 102 | 102 | 79 | 67 | 88 | 69 | 56 | 45 | 60 | 53 | 73 | 48 | 24 | 56 | 50 | 38 | 50 | 36 | 51 | 48 | 47 | 44 | 45 | 38 | 44 | 63 | 39 | 32 | 82 | 32 | 28 | 26 |
| EBITDA | 4 | 4 | 15 | -4 | 4 | 7 | 7 | 7 | 7 | 13 | 8 | 16 | 7 | 3 | 6 | 13 | 4 | 12 | 4 | 11 | 9 | 11 | 8 | 8 | 8 | 9 | 14 | 13 | 9 | 12 | 5 | 4 | 2 |
| Operating Profit Margin % | 1.00% | 2.00% | 12.00% | -11.00% | 1.00% | 5.00% | 5.00% | 7.00% | 12.00% | 15.00% | 11.00% | 11.00% | 8.00% | 7.00% | 4.00% | 17.00% | 6.00% | 17.00% | 7.00% | 14.00% | 13.00% | 15.00% | 11.00% | 9.00% | 10.00% | 11.00% | 15.00% | 23.00% | 15.00% | 9.00% | 13.00% | 13.00% | 6.00% |
| Depreciation | 9 | 9 | 9 | 9 | 4 | 9 | 9 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 1 | 1 |
| Interest | 3 | 4 | 4 | 3 | 1 | 3 | 3 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -7 | -8 | 3 | -15 | -1 | -5 | -6 | 5 | 4 | 10 | 6 | 14 | 5 | 2 | 4 | 11 | 2 | 10 | 2 | 9 | 7 | 9 | 6 | 6 | 6 | 7 | 12 | 11 | 7 | 11 | 3 | 4 | 2 |
| Tax | 1 | 1 | 3 | 2 | 1 | 4 | 2 | 2 | 2 | 3 | 2 | 4 | 1 | 0 | 1 | 3 | 1 | 3 | 1 | 3 | 0 | 3 | 1 | 2 | 1 | 2 | 4 | 7 | 2 | 4 | 1 | 1 | 0 |
| Net Profit | -9 | -9 | -1 | -18 | -3 | -9 | -8 | 2 | 2 | 7 | 4 | 10 | 4 | 1 | 3 | 8 | 2 | 8 | 1 | 6 | 7 | 7 | 5 | 4 | 5 | 5 | 8 | 4 | 5 | 7 | 3 | 3 | 2 |
| Earnings Per Share (₹) | -14.00 | -14.40 | -1.00 | -27.00 | -0.62 | -2.11 | -10.00 | 6.07 | 4.24 | 13.03 | 6.45 | 17.19 | 7.04 | 2.03 | 4.94 | 13.88 | 3.29 | 13.49 | 2.32 | 11.26 | 12.45 | 11.58 | 9.46 | 7.29 | 9.13 | 8.29 | 14.11 | 7.46 | 9.15 | 11.34 | 4.62 | 5.45 | 2.94 |
Related Pages for Bharat Parenterals
Additional stock information and data for BPLPHARMA
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||
| Total Assets | 649 | 504 | 350 | 226 | 199 | 188 | 159 | 132 | 111 | 120 |
| Current Assets | 356 | 260 | 184 | 144 | 148 | 132 | 118 | 91 | 64 | 72 |
| Fixed Assets | 252 | 210 | 42 | 41 | 45 | 33 | 35 | 34 | 31 | 35 |
| Capital Work in Progress | 31 | 25 | 99 | 26 | 0 | 12 | 1 | 0 | 0 | 0 |
| Investments | 5 | 0 | 0 | 12 | 43 | 0 | 2 | 1 | 1 | 0 |
| Other Assets | 360 | 269 | 209 | 148 | 111 | 142 | 121 | 98 | 79 | 86 |
| LIABILITIES | ||||||||||
| Total Liabilities | 649 | 504 | 350 | 226 | 199 | 188 | 159 | 132 | 111 | 120 |
| Current Liabilities | 90 | 75 | 13 | 14 | 11 | 3 | 4 | 2 | 4 | 7 |
| Non-Current Liabilities | ||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||
| Total Equity | 339 | 238 | 218 | 170 | 144 | 118 | 94 | 73 | 64 | 57 |
| Share Capital | 7 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves & Surplus | 324 | 191 | 177 | 160 | 138 | 113 | 88 | 67 | 58 | 51 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -27 | -5 | 22 | -1 | 25 | 14 | 20 | 6 | -2 | 0 |
| Investing Activities | -137 | -105 | -78 | -7 | -43 | -13 | -9 | -8 | -2 | 0 |
| Financing Activities | 156 | 110 | 61 | 9 | 11 | -3 | -4 | 4 | -8 | 0 |
| Net Cash Flow | -8 | 1 | 4 | 2 | -8 | -1 | 7 | 2 | -11 | 0 |